Home  |  About us  |  Editorial board  |  Current issue  |  Archives  |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 121Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
REVIEW ARTICLE
Year : 2017  |  Volume : 8  |  Issue : 1  |  Page : 41-44

Development of statistics as a discipline for clinical research: Past, present, and future


Chief Scientific Officer, Ph.D, Sciformix Corporation, US

Correspondence Address:
Chitra Lele
Sciformix Technologies Pvt Ltd., Akruti Softech Park, Road No. 21, MIDC, Andheri, Mumbai . 400 093, Maharashtra, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2229-3485.198548

Rights and Permissions

This article traces the history and evolution of statistics in the era of evidence based medicine, and focuses on the Indian perspective of this growth of statistics as a discipline for clinical research. Statistics will assume a more inter disciplinary form. Use of software other than SAS likely to grow further. In India, innovative statistical methods will help propel the development of biosimilars. The future is exciting with statistics being used for real world evidence, development of biosimilars, mining of adverse event data and becoming a core function in medicinal product development and lifecycle maintenance.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed299    
    Printed1    
    Emailed0    
    PDF Downloaded68    
    Comments [Add]    

Recommend this journal